Drugmakers, Doctors Rake in Billions Battling H1N1 Flu
Swine Flu Is Bad for Victims, But Good for Businesses That Cater to Expanding Market
By DALIA FAHMY
Oct. 14, 2009—


Americans are still debating whether to roll up their sleeves for a swine flu shot, but companies have already figured it out: vaccines are good for business.

Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market.